518A2
|
EC50 |
|
Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay
Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay
|
[PMID: 28033541]
|
518A2
|
IC50 |
|
Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay
Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay
|
[PMID: 24440377]
|
518A2
|
IC50 |
|
Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay
Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay
|
[PMID: 24361521]
|
518A2
|
IC50 |
|
Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay
Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay
|
[PMID: 24161703]
|
518A2
|
EC50 |
|
Anticancer activity against human 518A2 cells measured after 96 hrs by sulforhodamine B assay
Anticancer activity against human 518A2 cells measured after 96 hrs by sulforhodamine B assay
|
[PMID: 31330447]
|
518A2
|
EC50 |
|
Cytotoxicity against human 518A2 cells after 96 hrs by sulforhodamine B assay
Cytotoxicity against human 518A2 cells after 96 hrs by sulforhodamine B assay
|
[PMID: 30278332]
|
518A2
|
EC50 |
|
Cytotoxicity against human 518A2 cells after 96 hrs by sulforhodamine-B assay
Cytotoxicity against human 518A2 cells after 96 hrs by sulforhodamine-B assay
|
[PMID: 29529499]
|
518A2
|
EC50 |
|
Cytotoxicity against human 518A2 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay
Cytotoxicity against human 518A2 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay
|
[PMID: 27149037]
|
8505C
|
EC50 |
|
Cytotoxicity against human 8505C cells after 96 hrs by SRB assay
Cytotoxicity against human 8505C cells after 96 hrs by SRB assay
|
[PMID: 28033541]
|
8505C
|
IC50 |
|
Cytotoxicity against human 8505C cells after 96 hrs by SRB assay
Cytotoxicity against human 8505C cells after 96 hrs by SRB assay
|
[PMID: 24440377]
|
8505C
|
IC50 |
|
Cytotoxicity against human 8505C cells after 96 hrs by SRB assay
Cytotoxicity against human 8505C cells after 96 hrs by SRB assay
|
[PMID: 24361521]
|
8505C
|
IC50 |
|
Cytotoxicity against human 8505C cells after 96 hrs by SRB assay
Cytotoxicity against human 8505C cells after 96 hrs by SRB assay
|
[PMID: 24161703]
|
8505C
|
EC50 |
|
Anticancer activity against human 8505C cells measured after 96 hrs by sulforhodamine B assay
Anticancer activity against human 8505C cells measured after 96 hrs by sulforhodamine B assay
|
[PMID: 31330447]
|
8505C
|
EC50 |
|
Cytotoxicity against human 8505C cells after 96 hrs by sulforhodamine B assay
Cytotoxicity against human 8505C cells after 96 hrs by sulforhodamine B assay
|
[PMID: 30278332]
|
A2780
|
EC50 |
|
Cytotoxicity against human A2780 cells after 96 hrs by SRB assay
Cytotoxicity against human A2780 cells after 96 hrs by SRB assay
|
[PMID: 28033541]
|
A2780
|
IC50 |
|
Cytotoxicity against human A2780 cells after 96 hrs by SRB assay
Cytotoxicity against human A2780 cells after 96 hrs by SRB assay
|
[PMID: 24440377]
|
A2780
|
IC50 |
|
Cytotoxicity against human A2780 cells after 96 hrs by SRB assay
Cytotoxicity against human A2780 cells after 96 hrs by SRB assay
|
[PMID: 24361521]
|
A2780
|
IC50 |
|
Cytotoxicity against human A2780 cells after 96 hrs by SRB assay
Cytotoxicity against human A2780 cells after 96 hrs by SRB assay
|
[PMID: 24161703]
|
A2780
|
EC50 |
|
Anticancer activity against human A2780 cells measured after 96 hrs by sulforhodamine B assay
Anticancer activity against human A2780 cells measured after 96 hrs by sulforhodamine B assay
|
[PMID: 31330447]
|
A2780
|
EC50 |
|
Cytotoxicity against human A2780 cells after 96 hrs by sulforhodamine B assay
Cytotoxicity against human A2780 cells after 96 hrs by sulforhodamine B assay
|
[PMID: 30278332]
|
A2780
|
EC50 |
|
Cytotoxicity against human A2780 cells after 96 hrs by sulforhodamine-B assay
Cytotoxicity against human A2780 cells after 96 hrs by sulforhodamine-B assay
|
[PMID: 29529499]
|
A2780
|
EC50 |
|
Cytotoxicity against human A2780 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay
Cytotoxicity against human A2780 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay
|
[PMID: 27149037]
|
A549
|
EC50 |
|
Cytotoxicity against human A549 cells after 96 hrs by SRB assay
Cytotoxicity against human A549 cells after 96 hrs by SRB assay
|
[PMID: 28033541]
|
A549
|
IC50 |
|
Cytotoxicity against human A549 cells after 96 hrs by SRB assay
Cytotoxicity against human A549 cells after 96 hrs by SRB assay
|
[PMID: 24440377]
|
A549
|
IC50 |
|
Cytotoxicity against human A549 cells after 96 hrs by SRB assay
Cytotoxicity against human A549 cells after 96 hrs by SRB assay
|
[PMID: 24361521]
|
A549
|
IC50 |
|
Cytotoxicity against human A549 cells after 96 hrs by SRB assay
Cytotoxicity against human A549 cells after 96 hrs by SRB assay
|
[PMID: 24161703]
|
A549
|
EC50 |
|
Anticancer activity against human A549 cells measured after 96 hrs by sulforhodamine B assay
Anticancer activity against human A549 cells measured after 96 hrs by sulforhodamine B assay
|
[PMID: 31330447]
|
A549
|
EC50 |
|
Cytotoxicity against human A549 cells after 96 hrs by sulforhodamine B assay
Cytotoxicity against human A549 cells after 96 hrs by sulforhodamine B assay
|
[PMID: 30278332]
|
A549
|
EC50 |
|
Cytotoxicity against human A549 cells after 96 hrs by sulforhodamine-B assay
Cytotoxicity against human A549 cells after 96 hrs by sulforhodamine-B assay
|
[PMID: 29529499]
|
A549
|
EC50 |
|
Cytotoxicity against human A549 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay
Cytotoxicity against human A549 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay
|
[PMID: 27149037]
|
B16-F10
|
IC50 |
|
Cytotoxicity against mouse B16-F10 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
Cytotoxicity against mouse B16-F10 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
|
[PMID: 33956447]
|
B16-F10
|
IC50 |
|
Cytotoxicity against mouse B16-F10 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against mouse B16-F10 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 36542806]
|
B16-F10
|
IC50 |
36.2 μM
Compound: II, Maslinic acid
|
Growth inhibition of mouse B16F10 cells after 72 hrs by MTT assay
Growth inhibition of mouse B16F10 cells after 72 hrs by MTT assay
|
[PMID: 29471121]
|
B16-F10
|
IC50 |
36.2 μM
Compound: II; MA; Maslinic acid
|
Cytotoxicity against mouse B16F10 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against mouse B16F10 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 27128174]
|
B16-F10
|
IC50 |
36.2 μM
Compound: 2, MA, Maslinic acid
|
Cytotoxicity against mouse B16F10 cells after 72 hrs by MTT assay
Cytotoxicity against mouse B16F10 cells after 72 hrs by MTT assay
|
[PMID: 24480359]
|
BV-2
|
IC50 |
|
Anti-inflammatory in mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production pre-incubated before LPS challenge for 24 hrs by Griess reagent based assay
Anti-inflammatory in mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production pre-incubated before LPS challenge for 24 hrs by Griess reagent based assay
|
[PMID: 28358502]
|
FaDu
|
EC50 |
|
Cytotoxicity against human FADU cells after 96 hrs by sulforhodamine-B assay
Cytotoxicity against human FADU cells after 96 hrs by sulforhodamine-B assay
|
[PMID: 29529499]
|
HepG2
|
IC50 |
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
|
[PMID: 33956447]
|
HepG2
|
IC50 |
|
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 27797185]
|
HepG2
|
IC50 |
|
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by neutral red assay
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by neutral red assay
|
[PMID: 28318944]
|
HepG2
|
IC50 |
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 36542806]
|
HepG2
|
IC50 |
99.2 μM
Compound: II, Maslinic acid
|
Growth inhibition of human HepG2 cells after 72 hrs by MTT assay
Growth inhibition of human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 29471121]
|
HepG2
|
IC50 |
99.2 μM
Compound: II; MA; Maslinic acid
|
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 27128174]
|
HSC-T6
|
EC50 |
|
Antiproliferative activity against rat HSC-T6 cells assessed as reduction in cell proliferation measured after 48 hrs by MTT assay
Antiproliferative activity against rat HSC-T6 cells assessed as reduction in cell proliferation measured after 48 hrs by MTT assay
|
[PMID: 29353722]
|
HT-29
|
IC50 |
|
Cytotoxicity against human HT-29 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
Cytotoxicity against human HT-29 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
|
[PMID: 33956447]
|
HT-29
|
EC50 |
|
Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay
Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay
|
[PMID: 28033541]
|
HT-29
|
IC50 |
|
Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay
Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay
|
[PMID: 24440377]
|
HT-29
|
IC50 |
|
Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay
Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay
|
[PMID: 24361521]
|
HT-29
|
IC50 |
|
Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay
Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay
|
[PMID: 24161703]
|
HT-29
|
EC50 |
|
Anticancer activity against human HT-29 cells measured after 96 hrs by sulforhodamine B assay
Anticancer activity against human HT-29 cells measured after 96 hrs by sulforhodamine B assay
|
[PMID: 31330447]
|
HT-29
|
EC50 |
|
Cytotoxicity against human HT-29 cells after 96 hrs by sulforhodamine B assay
Cytotoxicity against human HT-29 cells after 96 hrs by sulforhodamine B assay
|
[PMID: 30278332]
|
HT-29
|
EC50 |
|
Cytotoxicity against human HT-29 cells after 96 hrs by sulforhodamine-B assay
Cytotoxicity against human HT-29 cells after 96 hrs by sulforhodamine-B assay
|
[PMID: 29529499]
|
HT-29
|
EC50 |
|
Cytotoxicity against human HT-29 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay
Cytotoxicity against human HT-29 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay
|
[PMID: 27149037]
|
HT-29
|
IC50 |
|
Cytotoxicity against human HT-29 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human HT-29 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 36542806]
|
HT-29
|
IC50 |
32.2 μM
Compound: II, Maslinic acid
|
Growth inhibition of human HT-29 cells after 72 hrs by MTT assay
Growth inhibition of human HT-29 cells after 72 hrs by MTT assay
|
[PMID: 29471121]
|
HT-29
|
IC50 |
32.2 μM
Compound: II; MA; Maslinic acid
|
Cytotoxicity against human HT-29 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human HT-29 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 27128174]
|
KB
|
IC50 |
|
Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by neutral red assay
Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by neutral red assay
|
[PMID: 28318944]
|
KB
|
ED50 |
|
Cytotoxicity against human KB cells by SRB assay
Cytotoxicity against human KB cells by SRB assay
|
[PMID: 16562832]
|
Lu1
|
IC50 |
|
Cytotoxicity against human Lu1 cells assessed as growth inhibition after 72 hrs by neutral red assay
Cytotoxicity against human Lu1 cells assessed as growth inhibition after 72 hrs by neutral red assay
|
[PMID: 28318944]
|
MCF7
|
IC50 |
|
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 27797185]
|
MCF7
|
IC50 |
|
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by neutral red assay
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by neutral red assay
|
[PMID: 28318944]
|
MCF7
|
EC50 |
|
Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay
Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay
|
[PMID: 28033541]
|
MCF7
|
EC50 |
|
Cytotoxicity against human MCF7 cells after 96 hrs by sulforhodamine B assay
Cytotoxicity against human MCF7 cells after 96 hrs by sulforhodamine B assay
|
[PMID: 30278332]
|
MCF7
|
IC50 |
|
Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay
Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay
|
[PMID: 24361521]
|
MCF7
|
IC50 |
|
Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay
Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay
|
[PMID: 24161703]
|
MCF7
|
EC50 |
|
Anticancer activity against human MCF7 cells measured after 96 hrs by sulforhodamine B assay
Anticancer activity against human MCF7 cells measured after 96 hrs by sulforhodamine B assay
|
[PMID: 31330447]
|
MCF7
|
EC50 |
|
Cytotoxicity against human MCF7 cells after 96 hrs by sulforhodamine-B assay
Cytotoxicity against human MCF7 cells after 96 hrs by sulforhodamine-B assay
|
[PMID: 29529499]
|
MCF7
|
EC50 |
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay
|
[PMID: 27149037]
|
MDCK
|
CC50 |
23.3 μM
Compound: Maslinic acid
|
Cytotoxicity against MDCK cells assessed as decrease in cell viability after 72 hrs
Cytotoxicity against MDCK cells assessed as decrease in cell viability after 72 hrs
|
[PMID: 29394063]
|
NCI-N87
|
IC50 |
|
Cytotoxicity against human NCI-N87 cells after 72 hrs by MTT assay
Cytotoxicity against human NCI-N87 cells after 72 hrs by MTT assay
|
[PMID: 27797185]
|
NIH3T3
|
IC50 |
|
Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay
Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay
|
[PMID: 24161703]
|
NIH3T3
|
IC50 |
|
Cytotoxic activity against mouse NIH/3T3 cells by SRB assay
Cytotoxic activity against mouse NIH/3T3 cells by SRB assay
|
[PMID: 26383128]
|
NIH3T3
|
EC50 |
|
Cytotoxicity against mouse NIH/3T3 cells measured after 96 hrs by sulforhodamine B assay
Cytotoxicity against mouse NIH/3T3 cells measured after 96 hrs by sulforhodamine B assay
|
[PMID: 31330447]
|
NIH3T3
|
EC50 |
|
Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay
Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay
|
[PMID: 28033541]
|
NIH3T3
|
IC50 |
|
Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay
Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay
|
[PMID: 24440377]
|
NIH3T3
|
EC50 |
|
Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by sulforhodamine B assay
Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by sulforhodamine B assay
|
[PMID: 30278332]
|
NIH3T3
|
EC50 |
|
Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by sulforhodamine-B assay
Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by sulforhodamine-B assay
|
[PMID: 29529499]
|
NIH3T3
|
EC50 |
|
Cytotoxicity against mouse NIH/3T3 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay
Cytotoxicity against mouse NIH/3T3 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay
|
[PMID: 27149037]
|
NIH3T3
|
IC50 |
|
Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay
Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay
|
[PMID: 24361521]
|
Sf21
|
IC50 |
|
Inhibition of human recombinant COX2 expressed in baculovirus infected sf21 cells assessed as decrease in PGE2 formation using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis
Inhibition of human recombinant COX2 expressed in baculovirus infected sf21 cells assessed as decrease in PGE2 formation using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis
|
[PMID: 31774676]
|